AZ and Novoheart create a 3D heart model
AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its kind. The ‘heart-in-a-jar’, Novoheart’s proprietary 3D human ventricular cardiac organoid chamber (hvCOC) technology, will be made from human stem cells and will replicate the key characteristics of heart failure. This will include preserved ejection fraction